Literature DB >> 2416216

Argyrophilic cells in 202 human mucinous breast carcinomas. Relation to histopathologic and clinical factors.

B B Rasmussen, C Rose, S M Thorpe, K W Andersen, K Hou-Jensen.   

Abstract

Two hundred two human, mucinous breast carcinomas were investigated for the presence of argyrophilic granules, and these granules were found in 25% of the cases. The granules were located in the cytoplasm and were heterogeneously distributed within the tumors. Tumors with granules were otherwise morphologically indistinguishable from those tumors without granules. The recurrence-free survival was independent of the presence of granules, and no relation was found to other clinical or histopathologic factors. Tumors with granules were found to be estrogen-receptor positive, and they appear to have a slightly less aggressive growth pattern than tumors without granules, but the difference is far from being statistically significant. It is concluded that there is no convincing evidence that this group of primary breast carcinomas with argyrophilia originates from APUD cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416216     DOI: 10.1093/ajcp/84.6.737

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Resected case of carcinoid tumor of the liver metastatic from the breast.

Authors:  M Imamura; H Yamauchi; T Namiki
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

2.  Mucinous Breast Cancer: a Review Study of 5 Year Experience from a Hospital-Based Series of Cases.

Authors:  Adrian Dumitru; Alexandru Procop; Andreea Iliesiu; Mircea Tampa; Luminita Mitrache; Mariana Costache; Maria Sajin; Anca Lazaroiu; Monica Cirstoiu
Journal:  Maedica (Buchar)       Date:  2015-03

Review 3.  Carcinomas of the breast with endocrine differentiation: a review.

Authors:  H M Maluf; F C Koerner
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Mucoid breast carcinomas: histology and prognosis.

Authors:  I S Fentiman; R R Millis; P Smith; J P Ellul; O Lampejo
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.